Thank you to all of the companies that participated in our 2017 Benchmarking Study, Value-Based Metrics. Results from the study will become available soon.
The DCAT Research & Benchmarking Task Force launched its second benchmarking survey, Value-Based Metrics, on May 9, 2017. The purpose of the survey, which is being conducted by DCAT along with an external research firm, is to provide our membership with valuable insights on the best practices and key metrics used by pharmaceutical companies and suppliers to measure the benefits of value-creation activities.
Who can participate:
The study sample will include both pharmaceutical companies and suppliers, excluding providers of supply-chain/logistics services, consultants, or other support services.
Get the results:
The final report will be made available to DCAT member companies in late September, and results will be formally presented during a webinar later in November.
DCAT Benchmarking is a complimentary service provided exclusively for DCAT member companies. To learn how to access a copy of DCAT's first benchmarking study, Value Creation in Pharmaceutical Procurement, click here.
DCAT Benchmarking is a member service delivering in-depth studies examining the crucial issues impacting the pharmaceutical manufacturing value chain. It is a valuable way for learning of best practices and key metrics for companies engaged in pharmaceutical development and manufacturing.
DCAT Benchmarking studies are developed by the DCAT Research & Benchmarking Task Force, composed of member representatives from diverse industry backgrounds and company experience, to identify the topics of greatest interest for DCAT member companies.
Using objective research methods, DCAT Benchmarking studies provide targeted insight for companies engaged in pharmaceutical development and manufacturing in key functional areas, including sourcing, procurement, supply management, and project management.
Have suggestions for future benchmarking studies? Contact DCAT’s Editorial Director and Staff Liaison for the Research & Benchmarking Task Force, Patricia Van Arnum at email@example.com.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.